published meta-analysis   sensitivity analysis   studies

chloroquine in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias clinical improvementdetailed resultsHuang, 2020 1.37 [0.73; 2.56] 1.37[0.73; 2.56]Huang, 202010%22NAnot evaluable clinical improvement (14-day)detailed resultsHuang, 2020 1.37 [0.73; 2.56] 1.37[0.73; 2.56]Huang, 202010%22NAnot evaluable hospital dischargedetailed resultsHuang, 2020 2.00 [1.15; 3.47] 2.00[1.15; 3.47]Huang, 202010%22NAnot evaluable radiologic improvement (14-day)detailed resultsHuang, 2020 1.33 [0.94; 1.88] 1.33[0.94; 1.88]Huang, 202010%22NAnot evaluable radiologic improvement (7-day)detailed resultsHuang, 2020 2.40 [0.26; 22.51] 2.40[0.26; 22.51]Huang, 202010%22NAnot evaluable viral clearance detailed resultsHuang, 2020 1.20 [0.78; 1.85] 1.20[0.78; 1.85]Huang, 202010%22NAnot evaluable viral clearance by day 14detailed resultsHuang, 2020 1.09 [0.95; 1.26] 1.09[0.95; 1.26]Huang, 202010%22NAnot evaluable viral clearance by day 7detailed resultsHuang, 2020 1.20 [0.60; 2.40] 1.20[0.60; 2.40]Huang, 202010%22NAnot evaluable adverse eventsdetailed resultsHuang, 2020 1.80 [0.14; 23.37] 1.80[0.14; 23.37]Huang, 202010%22NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-03-29 14:02 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 656 - roots T: 290